id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
489534,b4e7dfec-c7c7-4088-9b36-e995b04e00cc,YY,SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.,34502,SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C,2006,year_end,TRD,"Legislation regarding duty suspension for Ezetimibe:  H.R.2077, To suspend temporarily the duty on Garenoxacin mesylate; H.R.2079, To extend the temporary duty suspension on Ezetimibe; S.1551, Protecting Free Trade in Pharmaceuticals Act of 2005.
H.R.2077, To suspend temporarily the duty on Garenoxacin mesylate; H.R.2079, To extend the temporary duty suspension on Ezetimibe; S.1551, Protecting Free Trade in Pharmaceuticals Act of 2005.","HOUSE OF REPRESENTATIVES,SENATE",,820000,0,0,2007-02-14T14:11:41-05:00